RISE selected OFF-X to support the work of researchers in drug R&D to perform target safety assessment for early projects.
More info
Announced today, the Vall dĀ“Hebron Institute of Oncology - Bioinfogate collaboration will validate the utility of the OFF-X translational safety intelligence portal in the design of novel clinical trials, including first-in-human studies.
More info
Bioinfogate will be showcasing some of their recent developments at booth 133.
More info

We empower and accelerate
biomedical research by developing
unique data science solutions

Our advanced data analytics solutions address the challenges of molecular and biological complexity in drug discovery. We connect emerging data sources and life science content into advanced knowledge management platforms that deliver meaningful biomedical intelligence.

Learn more about our solutions

We inspire the scientific community by
revealing new gateways in drug R&D

Data science is revealing new ways to understand disease and pointing to promising, new therapeutic interventions. Researchers need a way to unlock new gateways in drug discovery to accelerate their R&D efforts. By tapping into our extensive network of thought leaders and harnessing more than 60 years of experience in scientific knowledge management, we are able to identify emerging trends in biomedical research and show how data science is enabling a new paradigm, transforming patient care.


We support and invest in early stage,
life science initiatives that share our vision

We invest and partner with academic research teams and startups pioneering innovative uses of data in the life sciences that align with our technologies and capabilities.

Learn more about our investment strategy